Abstract
The plant Glycyrrhiza glabra species (liquorice or licorice), a flowering plant of
the bean family Fabaceae, is of utmost importance as it contains glycyrrhizin, an important
antiviral compound along with other significant phytoconstituents like glycyrrhetinic acid,
glabrin A&B, triterpene sterols, isoflavones, and many more. Glycyrrhiza glabra has been
recognized for its ethnopharmacological values since time immemorial, as it exhibits various
pharmacological activities. The crux of this review focuses on the antiviral activity of liquorice
against several viruses that pose a severe threat to humankind like herpes simplex virus
(HSV), Hepatitis C virus (HCV), H5N1 virus, human immunodeficiency virus (HIV), H3N2
virus, influenza, and influenza A virus, pseudorabies virus (PrV), etc. Overall, This review
article explains the compilation of data obtained from Scopus indexed journal articles over 5
years ranging from 2015 to 2020, which not only aims to shed light on the application of
Glycyrrhiza glabra against human viruses but also on how to develop these responses further
to improve the efficacy. Further, the review also focuses on Glycyrrhiza glabra for its potential
commercial uses, such as treating the porcine virus in pigs and piglets, which is verified.
Keywords:
Glycyrrhiza glabra, bioactive constituents, polyphenols, antiviral, pharmacological properties, root
Graphical Abstract
[1]
Al-Snafi AE. Glycyrrhiza glabra: A phytochemical and pharmacological review. IOSR J Pharm 2018; 8(6): 1-17.
[6]
Sharma V, Katiyar A, Agrawal RC. Glycyrrhiza glabra: Chemistry and pharmacological activity Reference Series in Phytochemistry. Cham: Springer International Publishing 2018; pp. 87-100.
[15]
Kalsi S, Verma DSK. A review on Glycyrrhiza glabra (Liquorice) and its pharmacological activities. Int J Pharm Drug Anal 2016; 4(5): 09-234.
[20]
Vani S, Rajarajan S. A study on in vitro antiviral activities of lyophilized extracts of Glycyrrhiza glabra on hepatitis B virus. Int J Pharmacol Res 2016; 6(6): 09-206.
[34]
Pu J, He L, Xie H, et al. Promising anti-hepatitis C virus compounds from natural resources. Nat Prod Commun 2016; 11(8): 1193-200.
[38]
Kumar S, Dora BB. A critical appraisal on phytochemical constituents and therapeutic effect of yashtimadhu (Glycyrrhiza glabra). RRJoMST 2017; 6(3): 06-10.
[39]
Dissanayake KGC, Weerakoon WMTDN, Perera WPRT. Root/stem extracts of Glycyrrhiza glabra; As a medicinal plant against disease forming microorganisms. Int J Sci Basic Appl Res 2020; 51(1): 1-11.
[59]
Graebin CS. The pharmacological activities of glycyrrhizinic acid
(“Glycyrrhizin”) and glycyrrhetinic acid. In: Mérillon JM, Ramawat
K, Eds. Sweeteners Reference Series in Phytochemistry.
Cham: Springer 2018; pp. 245-61.
[69]
Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 46(3): 167- 92 2006.
[72]
Jain R, Shukla S, Nema N, Panday A, Gour HS. A systemic review: Structural mechanism of SARS-CoV-2A and promising preventive cure by phytochemicals. Int J Immunol Immunother 2020; 11: 1-6.
[75]
Sinha SK, Prasad SK, Islam MS, et al. Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: A pharmacoinformatics study. J Biomol Struct Dyn 2020; 0: 1-15.
[76]
Petric D. Glycyrrhizin and Coronaviruses Preprint 2020; 2020.
[82]
Hon KL, Leung KKY, Leung AKC, et al. Coronavirus disease 2019 (COVID-19): Latest developments in potential treatments COVID-19. Drugs Contexts 2020; 9: 2020-4-15.
[83]
Maurya DK. Evaluation of yashtimadhu (Glycyrrhiza glabra) active phytochemicals against novel coronavirus (SARS-CoV-2). Austin J Pharmacol Ther 2021; 9(6): 1153.
[85]
Mohammadi N, Shaghaghi N. Inhibitory effect of eight secondary metabolites from conventional medicinal plants on COVID_19 virus protease by molecular docking analysis. ChemRxiv 2020.